Sonoma Pharmaceuticals grants annual equity to executives and directors

Sonoma Pharmaceuticals, Inc.

Non-employee directors each received 10,000 options at $3.68, vesting in 3 equal annual tranches.
CEO Amy Trombly received 10,000 RSUs vesting on the third anniversary or upon change of control.
CFO Jerry Dvonch received 5,000 RSUs vesting on the third anniversary or upon change of control.

item 5.02

Sonoma Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-000027

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.